Corbus Pharmaceuticals Holdings Inc Pre-2026 ASCO Conference Call Transcript
Greetings and welcome to the Corpus Pharmaceuticals 2026 ASCO data update conference call webcast. (Operator Instructions) It's now my pleasure to turn the call over to Dan Ferry, Managing Director with LifeSci Advisors. Please go ahead, sir.
Thank you, operator. Good morning, everyone, and welcome to the Corvus Pharmaceuticals 2026 ASCO Data Update Call.
As a reminder, during this call, we will be making forward-looking statements, which are subject to various risks and uncertainties that could cause our actual results to differ materially from these statements.
Any such statements should be considered in conjunction with cautionary statements in our press releases and risk factors discussed in our filings.
With the SEC including our quarterly reports on Form 10-Q and annual report on Form 10-K and cautionary statements made during this call.
We assume no obligation to update any of these forward-looking statements or information.
It is now my pleasure to turn the call over
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
